Mizuho Analyst On The Fence At Medicines Co. Pending Patent Appeal
April 11, 2015 at 12:49 PM EDT
Uncertainty over patents on The Medicines Company (NASDAQ: MDCO)'s lead blood-clot drug Angiomax will hurt results going forward, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.